Loading...
•
Dec 31, 2019
OraSure Q4 2019 Earnings Report
Announced financial results for the three months and year ended December 31, 2019.
Key Takeaways
OraSure Technologies reported Q4 2019 net revenues of $49.7 million, a 1% decrease from Q4 2018. Net income for the quarter was $2.4 million, or $0.04 per share.
Net revenues for the fourth quarter of 2019 were $49.7 million, a 1% decrease from the fourth quarter of 2018.
Net product revenues were $47.2 million, a 5% increase from the fourth quarter of 2018.
International sales of the Company’s OraQuick® HIV products increased 123% compared to the fourth quarter of 2018.
Total microbiome product and service revenues in the fourth quarter of 2019 were $4.4 million compared to $1.9 million in the fourth quarter of 2018.
Forward Guidance
The Company expects consolidated net revenues for the year ended December 31, 2020 to range from $145.0 million to $155.0 million and is projecting a net loss of $0.07 to $0.10 per share.
Positive Outlook
- Focus on revenue growth by continuing to invest in our core businesses
- Leveraging our balance sheet to accelerate our innovation growth strategy
Challenges Ahead
- Net loss of $0.07 to $0.10 per share
- Projections do not account for the impact of changes in the fair value of acquisition-related contingent consideration
- Projections do not account for any potential transaction costs related to future business development activity
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...